Context Therapeutics's total assets for Q3 2024 were $86.33M, a decrease of -15.95% from the previous quarter. CNTX total liabilities were $2.47M for the fiscal quarter, a 54.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.